In vitro effect of homocysteine on some parameters of oxidative stress in rat hippocampus

Metabolic Brain Disease

Volumn 18, Issue 2, 2003, Pages 147-154

  Streck, Emilio L ^a   Vieira, Paula S ^a   Wannmacher, Clóvis M D ^a   Dutra Filho, Carlos S ^a   Wajner, Moacir ^a   Wyse, Angela T S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Antioxidant enzymes; Homocysteine; Homocystinuria; Oxidative stress; TBARS; TRAP

Indexed keywords

ANTIOXIDANT; BRAIN ENZYME; CATALASE; GLUTATHIONE PEROXIDASE; HOMOCYSTEINE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME ASSAY; HIPPOCAMPUS; HOMOCYSTINURIA; IN VITRO STUDY; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; RAT;

ANIMALS; CATALASE; FREE RADICAL SCAVENGERS; GLUTATHIONE PEROXIDASE; HIPPOCAMPUS; HOMOCYSTEINE; LIPID PEROXIDATION; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS;

EID: 0038509956     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023815119931     Document Type: Article

References (30)

1. Aebi, H. (1984). Catalase in vitro. Methods Enzymol. 105:121-126.
2. Cavalca, V., Cighetti, G., Bamonti, F., Loaldi, A., Bortone, L., Novembrino, C., De Franceschi, M., Belardinelli, R., and Guazzi, M.D. (2001). Oxidative stress and homocysteine in coronary artery disease. Clin. Chem. 47:887-892.
3. De Franchis, R., Sperandeo, M.P., Sebastio, G., and Andria, G. (1998). Clinical aspects of cystathionine β-synthase: How wide is the spectrum? Eur. J. Pediatr. 157(Suppl. 2):S67-S70.
4. Esterbauer, H., and Cheeseman, K.H. (1990). Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 186:407-421.
5. Fowler, B. (1997). Disorders of homocysteine metabolism. J. Inher. Metab. Dis. 20:270-285.
6. Halliwell, B. (1996). Free radicals, proteins and DNA: Oxidative damage versus redox regulation. Biochem. Soc. Trans. 24:1023-1027.
7. Halliwell, B., and Gutteridge, J.M.C. (1985). Oxygen radicals and nervous system. Trends Neurosci. 8:22-26.
8. Ho, P.I., Ortiz, D., Rogers, E., and Shea, T.B. (2002). Multiple aspects of homocysteine neurotoxicity: Glutamate excitotoxicity, kinase hyperactivation and DNA damage. J. Neurosci. Res. 70:694-702.
9. Hogg, N. (1999). The effect of cyst(e)ine on the auto-oxidation of homocysteine. Free Rad. Biol. Med. 27:28-33.
10. Kim, W.K., and Pae, Y.S. (1996). Involvement of N-methyl-D-aspartate receptor and free radical in homocysteine-mediated toxicity on rat cerebellar granule cells in culture. Neurosci. Lett. 216:117-120.
11. Kraus, J.P. (1998). Biochemistry and molecular genetics of cystathionine β-synthase deficiency. Eur. J. Pediatr. 157(Suppl. 2):S50-S53.
12. Kuhn, W., Roebroek, R., Blom, H., van Oppenraaij, D., Przuntek, H., Kretschmer, A., Buttner, T., Woitalla, D., and Muller, T. (1998). Elevated plasma levels of homocysteine in Parkinson's disease. Eur. Neurol. 40:225-227.
13. Leblhuber, F., Walli, J., Artner-Dworzak, E., Vrecko, K., Widner, B., Reibnegger, G., and Fuchs, D. (2000). Hyperhomocysteinemia in dementia. J. Neural Transm. 107:343-353.
14. Lees, G.J. (1993). Contributory mechanisms in the causation of neurodegenerative disorders. Neuroscience 54:287-322.
15. Lipton, S.A., Kim, W.K., Choi, Y.B., Kumar, S., D'Emilia, D.M., Rayudu, P.V., Arnelle, D.R., and Stamler, J.S. (1997). Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc. Natl. Acad. Sci. U.S.A. 94:5923-5928.
16. Lissi, E., Pascual, C., and Del Castillo, M.D. (1992). Luminol luminescence induced by 2,2′-azo-bis(2-amidinopropane) thermolysis. Free Radic. Res. Commun. 17:299-311.
17. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
18. Malinow, M.R. (1990). Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis. Circulation 81:2004-2006.
19. Mudd, S.H., Levy, H.L., and Skovby, F. (2001). Disorders of transulfuration. In (C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, eds.), The Metabolic and Molecular Bases of Inherited Disease. 8th edn., McGraw-Hill, New York, pp. 1279-1327.
20. Parnetti, L., Bottiglieri, T., and Lowenthal, D. (1997). Role of homocysteine in age-related vascular and non-vascular diseases. Aging (Milano) 9:241-257.
21. Reznick, A.Z., and Packer, L. (1993). In (G. Poli, E. Albano, and M.U. Dianzani, eds.), Free radicals: From Basic Science to Medicine, Birkhäuser, Basel, pp. 425-437.
22. Schurr, A. (2002). Energy metabolism, stress hormones and neural recovery from cerebral ischemia/hypoxia. Neurochem. Int. 41:1-8.
23. Seshadri, S., Beiser, A., Selhub, J., Jacques, P.F., Rosenberg, I.H., D'Agostino, R.B., Wilson, P.W.F., and Wolf, P.A. (2002). Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346:476-483.
24. +-ATPase activity induced by homocysteine is probably mediated by oxidative stress. Neurochem. Res. 26:1195-1200.
25. Temple, M.E., Luzier, A.B., and Kaazierad, D.J. (2000). Homocysteine as a risk factor for atherosclerosis. Ann. Pharmacother. 34:57-65.
26. Ueland, P.M., and Refsum, H. (1989). Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy. J. Lab. Clin. Med. 114:473-501.
27. Welch, G.N., Upchurch, G.R., and Loscalzo, J. (1997). Homocysteine, oxidative stress, and vascular disease. Hosp. Pract. 32:81-92.
28. Wendel, A. (1981). Glutathione peroxidase. Methods Enzymol. 77:325-332.
29. White, A.R., Huang, X., Jobling, M.F., Barrow, C.J., Beyreuther, K., Masters, C.L., Bush, A.I., and Cappai, R. (2001). Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: Possible risk factors in the Alzheimer's-type neurodegenerative pathways. J. Neurochem. 76:1509-1520.
30. +-ATPase activity in hippocampus of rats subjected to acute administration of homocysteine is prevented by vitamins E and C treatment. Neurochem. Res. 27:1677-1681.